Fatty acid inhibition reduces MYC expression in triple-negative breast cancer

被引：0
|
作者：
Sritharan, N. [1 ]
Lee, J. [1 ]
Goga, A. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
522
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [41] Triple-negative breast cancer
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (08) : 22 - 23
  • [42] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [43] Glycolysis inhibition for synergistic phototherapy of triple-negative breast cancer
    Fu, Yuqian
    Bai, Tingjie
    Xue, Panpan
    Chen, Qi
    Deng, Weili
    Yan, Shuangqian
    Zeng, Xuemei
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (44) : 10717 - 10727
  • [44] High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
    Torres-Ruiz, Sandra
    Tormo, Eduardo
    Garrido-Cano, Iris
    Lameirinhas, Ana
    Rojo, Federico
    Madoz-Gurpide, Juan
    Burgues, Octavio
    Hernando, Cristina
    Bermejo, Begona
    Martinez, Maria Teresa
    Lluch, Ana
    Cejalvo, Juan Miguel
    Eroles, Pilar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [45] Expression of fatty acid synthase as a prognostic marker in triple negative breast cancer
    Kong, S. H.
    Jeon, Y. S.
    Lee, S. J.
    Bae, Y. K.
    CANCER RESEARCH, 2009, 69 (02) : 130S - 130S
  • [46] Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
    Shen, Liangliang
    O'Shea, John M.
    Kaadige, Mohan R.
    Cunha, Stephanie
    Wilde, Blake R.
    Cohen, Adam L.
    Welm, Alana L.
    Ayer, Donald E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (17) : 5425 - 5430
  • [47] MYC-dependent transformation model of triple-negative breast cancer in vivo
    Lourenco, Corey
    Kalkat, Manpreet
    Dingar, Dharmesh
    De Melo, Jason
    Yu, Rosemary
    Penn, Linda
    CANCER RESEARCH, 2017, 77
  • [48] Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer
    Kunder, Ratika
    Velyunskiy, Michelle
    Dunne, Sara F.
    Cho, Byoung-Kyu
    Kanojia, Deepak
    Begg, Lauren
    Orriols, Adrienne M.
    Fleming-Trujillo, Erica
    Vadlamani, Pranathi
    Vialichka, Alesia
    Bolin, Rosemary
    Perrino, Jessica N.
    Roth, Diane
    Clutter, Matthew R.
    Zielinski-Mozny, Nicolette A.
    Goo, Young Ah
    Cristofanilli, Massimo
    Mendillo, Marc L.
    Vassilopoulos, Athanassios
    Horiuchi, Dai
    CELL CHEMICAL BIOLOGY, 2022, 29 (03) : 358 - +
  • [49] Significance of the combination of biguanides and fatty acid β-oxidation inhibitors in triple-negative breast cancer.
    Park, Junhyoung
    Jung, Kwang Hwa
    Jia, Dongya
    Yang, Sukjin
    Sakthivel, Dharaniya
    Tiwari, Abha
    Onuchic, Jose N.
    Kaipparettu, Benny Abraham
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Cancer-testis antigen expression in triple-negative breast cancer
    Curigliano, G.
    Viale, G.
    Ghioni, M.
    Jungbluth, A. A.
    Bagnardi, V.
    Spagnoli, G. C.
    Neville, A. M.
    Nole, F.
    Rotmensz, N.
    Goldhirsch, A.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 98 - 103
12345